RANGE CANCER THERAPEUTICS ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.39 USD | +3.15% |
|
+0.21% | +6.83% |
| Current month | -13.42% | ||
| 1 month | -8.92% |
Investment objective
The Loncar Cancer Immunotherapy ETF trades on Nasdaq under the symbol CNCR. It is made of up a basket of companies that develop therapies to treat cancer by harnessing the body's own immune system. Immunotherapy is a transformational field within the biotechnology space that may have a foundational impact on cancer care. By developing immunotherapies that are more effective and deliver a better quality of life than currently available medicines, innovative immunotherapy companies may be making a difference for courageous patients who battle cancer. Our fund seeks to support this important work and its positive impact on society. It tracks the LCINDX index.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 7.35 USD | +43.84% | +39.47% | +46.41% | 2.84% | ||
| 35.96 USD | +1.78% | +2.98% | +25.38% | 2.32% | ||
| 4 USD | -1.96% | -11.50% | -37.89% | 2.27% | ||
| 14.56 USD | +1.32% | -6.73% | +51.35% | 2.09% | ||
| 93 USD | +2.50% | +7.08% | +0.82% | 1.77% | ||
| 3.8 USD | -1.81% | -20.67% | +1.60% | 1.76% | ||
| 51.92 USD | +1.05% | +0.52% | -6.45% | 1.69% | ||
| 32.37 USD | +2.44% | -6.77% | -21.36% | 1.69% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 14.39 | +3.15% | 3,231 |
| 24-04-25 | 13.95 | -1.97% | 6,400 |
| 24-04-24 | 14.23 | -1.73% | 2,207 |
| 24-04-23 | 14.48 | +1.90% | 2,486 |
| 24-04-22 | 14.21 | +0.71% | 6,832 |
Other stock markets
Delayed Quote Nasdaq
Last update April 26, 2024 at 04:15 pm EDT
More quotesDescription
| US26922A8264 | |
|---|---|
| Total Expense Ratio | 0.79% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | Range Oncology Therapeutics Index - USD |
Features and characteristics
| Jurisdiction | |
| Fund Structure | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2015-03-17
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-03-27 )
| AuM (EUR) | 27 M€ |
|---|---|
| AuM 1M | 18 M€ |
| AuM 3 months | 13 M€ |
| AuM 6 months | 8 M€ |
| AuM 12 months | 16 M€ |
- Stock Market
- ETF
- CNCR ETF
